Chapters
Transcript
Dana-Farber's Jia Luo, MD, details on findings from the NUT Carcinoma Registry on initial chemotherapy for locally advanced and metastatic disease.
Related Presenters
Jia Luo, MD
Medical Oncology
View Full Profile
Related Videos
ASCO 2023: Bladder Cancer Highlights Presented By Charlene Mantia, MD
ASCO 2023: Prostate Cancer Highlights Presented By Jacob Berchuck, MD
ASCO 2023: Kidney Cancer Highlights Presented By Vincent (Wenxin) Chu, MD
ASCO 2023: Kidney Cancer Research Presented by Toni Choueiri, MD
ASCO 2023: Breast Cancer Research Presented by Jennifer Ligibel, MD
ASCO 2023: Prostate Cancer Research Presented by Praful Ravi, MB BCHIR, MRCP
ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD
ASCO 2023: Breast Cancer Research Presented by Paolo Tarantino, MD
ASCO 2023: Head And Neck Research Presented by Glenn Hanna, MD
Marla Lipsyc-Sharf, MD on ctDNA in Breast Cancer
Impact of Angiotensin Blockade on Response to PD1/L1 Inhibitors for Patients with Metastatic Urothelial Carcinoma (mUC)
Post-Radical Prostatectomy (RP) Outcome for Patients with High-Risk Prostate Cancer Treated with Intense Neoadjuvant Hormone Therapy (NHT): Results of a Pooled Analysis of Contemporary Clinical Trials
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account